News and Events

    How the Pfizer-BioNTech Vaccine Works

    The German company BioNTech partnered with Pfizer to develop and test a coronavirus vaccine known as BNT162b2, the generic name tozinameran or the brand name Comirnaty. A clinical trial demonstrated that the vaccine has an efficacy rate of 95 percent in preventing Covid-19.

    Read more at nytimes.com.

    Prev Next

    30 Aug 2021

    Roal 30 vuotta

    28 Nov 2018

    Synbio Powerhouse

    IBC Finland ry
    c/o Clic Innovation Ltd
    Eteläranta 10, 5th floor
    FI-00130 Helsinki

    IBC Finland builds novel biotechnology solutions and products through project cooperation between companies and research institutes. We offer industry the opportunity to achieve sustainable processing and production of biobased products, chemicals, materials and fuels, from renewable raw materials using biotechnology.

    Read about our Privacy Policy.